BAC vs DMAC · P/E 13, rev $113.10B vs $157.4M cap
Bank of America Corp (BAC) versus DiaMedica Therapeutics Inc (DMAC) — a side-by-side from cached financials, not a winner call.
Bank of America Corp (BAC) is a banks - diversified company listed on US. It is led by Brian Moynihan.
DiaMedica Therapeutics Inc (DMAC) is a biotechnology company listed on US.
Latest reported BAC revenue for 2025-12-31 was $113.10B. Net income was $30.51B. Revenue was up 11.0% from 2024-12-31 to 2025-12-31. BAC currently screens at market cap $382.01B and trailing P/E 13.4.
DMAC does not have a complete income-statement cache yet.
BAC currently screens at market cap $382.01B and trailing P/E 13.4. DMAC currently screens at market cap $157.4M.
Not investment advice. Open the BAC and DMAC stock pages for the full models.
Not investment advice.